Nephrology News
Kidney Cancer Survival Better Among Metformin Users
Patients who used the drug had a 38% lower risk of dying from kidney cancer than non-users, meta-analysis shows.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/